SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers.
Saved in:
| Title: | SOS1: tracking the evolving path from promising to actionable therapeutic target in RAS-dependent cancers. |
|---|---|
| Authors: | Luna-Ramírez L; Department of Medical Physiology and Biophysics, University of Seville and Institute of Biomedicine of Seville (IBiS)/'Virgen del Rocío' University Hospital/CSIC/University of Seville, Seville, Spain., García-Navas R; Lab 1. Cancer Research Center, CSIC-University of Salamanca and CIBERONC, Salamanca, 37007, Spain., Santos E; Lab 1. Cancer Research Center, CSIC-University of Salamanca and CIBERONC, Salamanca, 37007, Spain. esantos@usal.es., Baltanás FC; Department of Medical Physiology and Biophysics, University of Seville and Institute of Biomedicine of Seville (IBiS)/'Virgen del Rocío' University Hospital/CSIC/University of Seville, Seville, Spain. fcalvo@us.es. |
| Source: | Molecular cancer [Mol Cancer] 2026 Mar 26; Vol. 25 (1). Date of Electronic Publication: 2026 Mar 26. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-026-02632-7 |
